August 16, 2017 / 8:08 PM / 2 years ago

BRIEF-Immunomedics reports Q4 loss per share $0.48

Aug 16 (Reuters) - Immunomedics Inc

* Immunomedics announces fiscal 2017 results and strategic developments; reiterates guidance on bla submission timeline

* Q4 revenue fell 33 percent to $600,000

* Q4 revenue view $2.3 million — Thomson Reuters I/B/E/S

* Q4 loss per share $0.48

* Q4 earnings per share view $-0.12 — Thomson Reuters I/B/E/S

* Immunomedics Inc - ‍cash, cash equivalents, and marketable securities totaled $154.9 million as of june 30, 2017​

* Immunomedics Inc - ‍company expects to present final results of IMMU-132 in mtnbc that will form basis of bla submission later this year​

* Immunomedics Inc - ‍believe that current financial resources are sufficient to support operations through september 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below